Market revenue in 2023 | USD 655.7 million |
Market revenue in 2030 | USD 1,048.4 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.82% in 2023. Horizon Databook has segmented the Canada formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
Canada has one of the largest numbers of biotechnology companies in the world, with 821 biotech companies reported as of 2021, and is the largest market for the vaccine industry. The country accounts for 4% of the total number of globally registered clinical trials and is ranked fourth in terms of clinical sites.
The presence of a well-established healthcare system and support from the government is expected to result in an increased number of research and development activities in the country. For instance, on January 2023, the government of Canada announced the ‘Clinical Trials Fund’ estimated at USD 250 Million across three different funding streams with the motive of strengthening clinical trial infrastructure, research, and training by 2025.
These factors are anticipated to contribute to the demand for formulation development services in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Canada formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account